Basic Information
Basic information for LINC01010-202-13aa
Peptide Name LINC01010-202-13aa
Genome Position chr6:134503381-134503419[+]
Species Human
Peptide Sequence MPCICKQGLVGYE
Peptide Length 13
Unique No (LINC01010-201-13aa,LINC01010-203-13aa,LINC01010-204-13aa,LINC01010-205-13aa,LINC01010-206-13aa,LINC01010-207-13aa,LINC01010-208-13aa,LINC01010-209-13aa,LINC01010-210-13aa,LINC01010-211-13aa,LINC01010-212-13aa,LINC01010-213-13aa,LINC01010-214-13aa,LINC01010-215-13aa,LINC01010-216-13aa)
Grand Average of Hydropathicity 0.3692
Relative Molecular Mass 1656.95
Experimental Evidences 2:m6A,ribo
lncRNA ID/Name ENSG00000236700;LINC01010
Transcript ID/Name ENST00000440090;LINC01010-202
Transcript Length 1445
Coding Ability 0.4588
DNA Sequence Corresponding to Peptide ATGCCCTGCATTTGCAAACAAGGATTAGTAGGGTATGAG
Experimental Evidences
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :